During the past decade, CyberKnife Centers of Tampa Bay conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CyberKnife Centers of Tampa Bay" #1 collaborator was "CyberKnife Coalition" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CyberKnife Centers of Tampa Bay" are "Ductal Carcinoma in Situ" (1 trials), "Invasive Ductal Carcinoma of Female Breast" (1 trials), "Prostate Cancer Early Risk Treated by Radiosurgery" (1 trials) and "Prostate Cancer Intermediate Risk Treated by Radiosurgery" (1 trials). Many other conditions were trialed in "CyberKnife Centers of Tampa Bay" in a lesser frequency.

Most popular intervention types in "CyberKnife Centers of Tampa Bay" are "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "stereotactic body radiation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "CyberKnife Centers of Tampa Bay" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CyberKnife Centers of Tampa Bay". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CyberKnife Centers of Tampa Bay, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CyberKnife Centers of Tampa Bay, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".